Allogene Therapeutics to participate in three investor conferences in November and December.

lunes, 10 de noviembre de 2025, 8:32 am ET1 min de lectura
ALLO--

Allogene Therapeutics, a biotech company, will participate in three investor conferences in November and December. The events include TD Cowen's Immunology & Inflammation Virtual Summit, Jefferies Global Healthcare Conference in London, and Piper Sandler 37th Annual Healthcare Conference. The company's AlloCAR T products are being developed for cancer and autoimmune disease. Webcasts of the events will be available on Allogene's website.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios